TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 49 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $827,003 | -38.8% | 1,251,139 | -27.4% | 0.08% | -23.1% |
| Q1 2023 | $1,350,706 | -80.1% | 1,722,400 | -42.6% | 0.10% | -76.3% |
| Q4 2022 | $6,779,469 | +108.9% | 2,999,765 | +86.2% | 0.44% | +109.0% |
| Q3 2022 | $3,246,000 | -46.9% | 1,610,822 | -2.0% | 0.21% | -31.6% |
| Q2 2022 | $6,114,000 | -29.7% | 1,643,438 | +23.2% | 0.31% | -20.3% |
| Q1 2022 | $8,697,000 | -48.7% | 1,333,947 | -8.4% | 0.38% | -35.5% |
| Q4 2021 | $16,964,000 | -27.1% | 1,456,147 | +16.6% | 0.60% | -18.6% |
| Q3 2021 | $23,262,000 | +154.0% | 1,249,309 | +189.1% | 0.73% | +181.9% |
| Q2 2021 | $9,160,000 | +1121.3% | 432,072 | +1069.2% | 0.26% | +1081.8% |
| Q1 2021 | $750,000 | -64.0% | 36,956 | -53.0% | 0.02% | -66.2% |
| Q4 2020 | $2,085,000 | +24.1% | 78,576 | +4.8% | 0.06% | +27.5% |
| Q3 2020 | $1,680,000 | – | 75,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
| Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
| Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
| Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
| Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
| Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
| TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
| Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |